Further studies are needed to investigate the pharmacogenetic relationships between KCNH7 and risperidone in bipolar disorder and autism, and the possible role of KCNH7 in the treatment efficacy of risperidone in bipolar disorder remains to be investigated. The gene discussed is KCNH7; the disease is bipolar disorder.